Adaptyv Biosystems will use the Series A to expand laboratory capacity, open a London lab and office, and develop more advanced biological workflows.
- Amount
- $40M
- Stage
- Series A
- Announced
- 26 August 2026
- Lead
- Highland Europe
- Other investors
- Ace Ventures, ByFounders, Y Combinator
- Use of funds
- Triple lab capacity by end of 2026, open a London lab and office, grow the team from 25 to about 60, and add harder biology workflows.
- Checked
- Amount and date checked against the press source